National Health Investors, Inc. carries a market capitalization of 3.45B, placing it among publicly traded companies globally. Its enterprise value stands at 5.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.45B |
| Enterprise Value | 5.11B |
National Health Investors, Inc. currently has 48.46M shares outstanding.
| Shares Outstanding | 48.46M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
National Health Investors, Inc. trades at a trailing price-to-earnings ratio of 25.95. The price-to-sales ratio is 9.57, and the price-to-book ratio stands at 1.38.
| PE Ratio | 25.95 |
| PS Ratio | 9.57 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 15.84 |
| P/OCF Ratio | 15.78 |
On an enterprise value basis, National Health Investors, Inc. trades at an EV/EBITDA multiple of 18.20 and an EV/FCF ratio of 17.12. The EV/Sales ratio of 12.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.17 provides insight into valuation relative to core operating earnings.
| EV / Sales | 12.72 |
| EV / EBITDA | 18.20 |
| EV / EBIT | 26.17 |
| EV / FCF | 17.12 |
National Health Investors, Inc. maintains a current ratio of 0.83, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.85, indicating elevated leverage, while an interest coverage ratio of 5.12 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.83 |
| Quick Ratio | 0.82 |
| Debt / Equity | 82.85 |
| Debt / EBITDA | 4.53 |
| Interest Coverage | 5.12 |
National Health Investors, Inc. posts a return on equity of 5.46 and a return on invested capital of 7.08.
| Return on Equity (ROE) | 5.46 |
| Return on Assets (ROA) | 5.22 |
| Return on Invested Capital (ROIC) | 7.08 |
| Return on Capital Employed (ROCE) | 5.11 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
National Health Investors, Inc.'s stock has declined approximately -0.96100279% over the past 52 weeks. The 50-day moving average sits at 78.95, while the 200-day moving average is 79.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.96100279% |
| 50-Day Moving Average | 78.95 |
| 200-Day Moving Average | 79.27 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, National Health Investors, Inc. generated 401.46M in revenue and converted that into 148.11M in net income, yielding earnings per share of 3.07. EBITDA reached 280.55M, while operating income came in at 195.07M.
| Revenue | 401.46M |
| Gross Profit | 390.56M |
| Operating Income | 195.07M |
| Pretax Income | 146.72M |
| Net Income | 148.11M |
| EBITDA | 280.55M |
| EBIT | 195.07M |
| Earnings Per Share (EPS) | 3.07 |
National Health Investors, Inc. holds 24.95M in cash and equivalents against 1.27B in total debt, resulting in a net debt position of 1.24B. Total book value stands at 2.79B, with working capital of -68.29M providing operational flexibility.
| Cash & Cash Equivalents | 24.95M |
| Total Debt | 1.27B |
| Net Debt | 1.24B |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 58.65 |
| Working Capital | -68.29M |
National Health Investors, Inc. produced 243.53M in operating cash flow over the past twelve months.
| Operating Cash Flow | 243.53M |
| Capital Expenditures | N/A |
| Free Cash Flow | 243.53M |
| FCF Per Share | 5.12 |
National Health Investors, Inc. operates with a gross margin of 97.29, reflecting its pricing power and cost economics. The operating margin of 48.59 and net profit margin of 36.89 provide insight into operational efficiency.
| Gross Margin | 97.29 |
| Operating Margin | 48.59 |
| Pretax Margin | 36.55 |
| Profit Margin | 36.89 |
| EBITDA Margin | 69.88 |
The company's payout ratio of 119.05 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 3.64 |
| Dividend Yield | N/A |
| Payout Ratio | 119.05 |
| Shareholder Yield | 1.52 |
| FCF Yield | 6.31 |
National Health Investors, Inc. posts an Altman Z-Score of 3.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.38 |